Hydrocortisone improves post-resuscitation myocardial dysfunction by inhibiting the NF-κB pathway
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2024-0162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Yaqin Fang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, The Emergency Depar…. Hauptthemen laut MEDLINE: NF-kappa B, Myocytes, Cardiac, Hydrocortisone, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Fundamental Research Program of Shanxi Province.
Themen: Reanimation
Abstract (Originalsprache)
Myocardial dysfunction is a major cause of early mortality after successful cardiopulmonary resuscitation (CPR) following cardiac arrest (CA). Following the return of spontaneous circulation, myocardial ischemia–reperfusion injury can activate the NF-κB pathway, leading to the transcription of inflammatory genes that impair myocardial function. While clinical studies show hydrocortisone (HC) improves outcomes in CA patients during CPR, its specific role in modulating the NF-κB pathway is unclear. In this study, we established an in vitro model by inducing hypoxia/reoxygenation (H/R) injury in H9C2 cardiomyocytes using Na 2 S 2 O 4 , followed by HC treatment. The results showed that HC treatment of H/R-injured cardiomyocytes promoted proliferation, inhibited apoptosis, and suppressed the NF-κB pathway, thereby reducing interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-α) levels. Moreover, inhibition of the NF-κB pathway enhanced the proliferative capacity of H/R cardiomyocytes, decreased apoptosis rates, and reduced IL-6, IL-8, and TNF-α expression levels, with these effects being further amplified by HC treatment. These findings were further supported by in vivo experiments. In conclusion, our study suggests that HC may promote H/R cardiomyocyte proliferation, inhibit apoptosis, and alleviate inflammatory responses by suppressing the NF-κB pathway, providing new evidence to support its potential clinical application in CA management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, The Emergency Department, Taiyuan 030032, China.
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Department of Clinical Laboratory, Taiyuan 030032, China.
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Department of General Surgery, Taiyuan 030032, China.
ORCID-Profile: Yaqin Fang, Fenglin Song, Chunyan Gao, Zhiming Wang
Förderung
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Fang, Y., Song, F., Gao, C., & Wang, Z. (2025). Hydrocortisone improves post-resuscitation myocardial dysfunction by inhibiting the NF-κB pathway. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0162
Vancouver
Fang Y, Song F, Gao C, Wang Z. Hydrocortisone improves post-resuscitation myocardial dysfunction by inhibiting the NF-κB pathway. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0162
BibTeX
@article{Fang2025,
author = {Fang, Yaqin and Song, Fenglin and Gao, Chunyan and Wang, Zhiming},
title = {Hydrocortisone improves post-resuscitation myocardial dysfunction by inhibiting the NF-κB pathway},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2024-0162}
}
EUVIMED